Search research articles
Contact Us
Filters
Showing results (11-20 of 243) with videos related to
Page
of 25
Sort By:
Pharmacology & Therapeutics
|
February 22, 2011
Immune system to brain signaling: neuropsychopharmacological implications
Lucile Capuron, Andrew H Miller
Biological Psychiatry
|
December 4, 2004
Cytokines and psychopathology: lessons from interferon-alpha
Lucile Capuron, Andrew H Miller
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 20, 2025
The new normal: neural network adaptations in late-life depression
Ebrahim Haroon, Andrew H Miller
Modern Trends in Pharmacopsychiatry
|
July 25, 2017
Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders
Ebrahim Haroon, Andrew H Miller
Current Topics in Behavioral Neurosciences
|
November 11, 2016
Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
Ebrahim Haroon, Andrew H Miller
Progress in Neurobiology
|
April 27, 2010
Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression
Richard C Shelton, Andrew H Miller
Expert Opinion on Therapeutic Targets
|
January 23, 2008
Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs
Charles J Malemud, Andrew H Miller
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 10, 2013
Neurotherapeutic implications of brain-immune interactions
Jennifer C Felger, Andrew H Miller
Nature Reviews. Immunology
|
December 30, 2015
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H Miller, Charles L Raison
Dialogues in Clinical Neuroscience
|
April 14, 2011
Inflammation in depression: is adiposity a cause?
Richard C Shelton, Andrew H Miller
Page
of 25
Search research articles
Search
Showing results (11-20 of 243) with videos related to
Sort By:
Page
of 25
Pharmacology & Therapeutics
|
February 22, 2011
Immune system to brain signaling: neuropsychopharmacological implications
Lucile Capuron, Andrew H Miller
Biological Psychiatry
|
December 4, 2004
Cytokines and psychopathology: lessons from interferon-alpha
Lucile Capuron, Andrew H Miller
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 20, 2025
The new normal: neural network adaptations in late-life depression
Ebrahim Haroon, Andrew H Miller
Modern Trends in Pharmacopsychiatry
|
July 25, 2017
Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders
Ebrahim Haroon, Andrew H Miller
Current Topics in Behavioral Neurosciences
|
November 11, 2016
Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
Ebrahim Haroon, Andrew H Miller
Progress in Neurobiology
|
April 27, 2010
Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression
Richard C Shelton, Andrew H Miller
Expert Opinion on Therapeutic Targets
|
January 23, 2008
Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs
Charles J Malemud, Andrew H Miller
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 10, 2013
Neurotherapeutic implications of brain-immune interactions
Jennifer C Felger, Andrew H Miller
Nature Reviews. Immunology
|
December 30, 2015
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H Miller, Charles L Raison
Dialogues in Clinical Neuroscience
|
April 14, 2011
Inflammation in depression: is adiposity a cause?
Richard C Shelton, Andrew H Miller
Page
of 25